Company intelligence / Profile preview

FenX

Ownership: Private
Development stage: Other

Overview

Fenix Group International is an active global consulting firm specializing in management consulting services for life science companies. The company provides market insights, research, analysis, knowledge management, decision support, and contextualized software engineering through its proprietary platforms. Its expertise spans high-growth chronic and specialty disease states including cardiovascular/metabolism, endocrinology, oncology, neurology, infectious disease, and rare diseases. It does not develop drugs or own therapeutic pipelines but supports biopharma clients with strategic advisory services.

Industry: Consulting

Partnerships

Not specified; works with various life sciences companies as clients.

Beyond the preview

Go deeper on FenX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FenX.

Explore the full profile